Glycoprotein IIb-IIIa inhibitor

From Citizendium
Revision as of 09:09, 17 October 2010 by imported>Gareth Leng
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
This article is a stub and thus not approved.
 Main Article
 Discussion
Definition [?]
 Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
https://en.citizendium.org/wiki/index.php?title=Glycoprotein_IIb-IIIa_inhibitor&printable=yes
This editable Main Article is under development and subject to a disclaimer.

Glycoprotein IIb/IIIa inhibitors include eptifibatide and tirofiban. These medication block the platelet glycoprotein GPIIb-IIIa complex and are used for treating acute coronary syndromes.[1]

References

  1. ↑ Hillis LD, Lange RA (2009). "Optimal management of acute coronary syndromes.". N Engl J Med 360 (21): 2237-40. DOI:10.1056/NEJMe0902632. PMID 19458369. Research Blogging.
Retrieved from "https://citizendium.org/wiki/index.php?title=Glycoprotein_IIb-IIIa_inhibitor&oldid=706467"